NCT07383714 Nudging Parental Actions for Youth Suicide Prevention
| NCT ID | NCT07383714 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas Southwestern Medical Center |
| Condition | Suicide |
| Study Type | INTERVENTIONAL |
| Enrollment | 129 participants |
| Start Date | 2026-06-10 |
| Primary Completion | 2027-08-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 129 participants in total. It began in 2026-06-10 with a primary completion date of 2027-08-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the study is to determine effectiveness of a behaviorally informed text messaging intervention to help parents increase safety practices and reduce their teens' access to lethal means following a suicide-related emergency department visit.
Eligibility Criteria
Inclusion Criteria: * Guardian must be able and willing to provide informed consent, and the participant must be able and willing to provide assent. * Parent and adolescent willingness and ability to participate in study procedures and complete assessments at baseline, 6 weeks, and 12 weeks. * Presentation to the ED for a suicide-related emergency, defined as suicidal ideation within the last 2 weeks or a suicide attempt within the past month. * Adolescents aged 12-17 years during the consent. * Access to a mobile phone with text messaging capability for the parent/legal guardian. * Ability to communicate in English. Exclusion Criteria: * Absence of a legal guardian capable of providing consent. * Parents/legal guardians without access to a mobile phone with texting capability. * Inability to communicate in English. * Adolescents in state custody or under legal restrictions that prevent study participation. * Adolescents involved in the justice system in a manner that would interfere with study participation. * Adolescents with autism spectrum disorder or intellectual development disorder needing substantial or very substantial support
Contact & Investigator
Emine Rabia Ayvaci, MD
PRINCIPAL INVESTIGATOR
University of Texas Southwestern Medical Center
Frequently Asked Questions
Who can join the NCT07383714 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 17 Years, studying Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07383714 currently recruiting?
Yes, NCT07383714 is actively recruiting participants. Contact the research team at matthew.nguyen@UTSouthwestern.edu for enrollment information.
Where is the NCT07383714 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT07383714 clinical trial?
NCT07383714 is sponsored by University of Texas Southwestern Medical Center. The principal investigator is Emine Rabia Ayvaci, MD at University of Texas Southwestern Medical Center. The trial plans to enroll 129 participants.